Core Viewpoint - The company, Fengbei Biological Technology Co., Ltd., is set to go public on the Shanghai Stock Exchange, aiming to raise 1 billion yuan for expansion projects in the waste oil resource utilization sector [1][3]. Financial Performance - The company has experienced declining revenue and net profit from 2022 to 2024, with revenues of 1.71 billion yuan, 1.73 billion yuan, and 1.95 billion yuan, and net profits of 135.92 million yuan, 123.04 million yuan, and 115.32 million yuan respectively, indicating a downward trend [3]. - The sales prices of the company's main products have also shown a downward trend during the same period [3][4][5]. Product Pricing - The sales prices for the company's biodiesel formulation products decreased from 0.77 million yuan/ton in 2022 to 0.61 million yuan/ton in 2024, while industrial-grade mixed oil prices fell from 0.91 million yuan/ton to 0.62 million yuan/ton [4]. - The sales prices for biofuels and oil chemical products also declined, with biofuels dropping from 0.98 million yuan/ton to 0.73 million yuan/ton, and oil chemical products from 1.18 million yuan/ton to 0.89 million yuan/ton [5]. Inventory and Liabilities - The company's inventory has been increasing, with values of 104.24 million yuan, 198.38 million yuan, and 242.01 million yuan from 2022 to 2024, indicating a growing stockpile [6]. - The raw materials, primarily waste oil and industrial-grade mixed oil, accounted for a rising proportion of total inventory, increasing from 30.77% in 2022 to 40.71% in 2024 [6]. - The company has a significant amount of current liabilities, with total current liabilities of 373.14 million yuan, 336.64 million yuan, and 358.53 million yuan over the same period, primarily consisting of short-term loans and accounts payable [7][8]. Legal Issues - The company is involved in ongoing litigation related to a fire incident at a leased facility, which resulted in significant inventory losses and subsequent lawsuits from various parties [10][11].